Anthracycline News and Research

RSS
Anthracycline is a type of antibiotic that comes from certain types of Streptomyces bacteria. Anthracyclines are used to treat many types of cancer. Anthracyclines damage the DNA in cancer cells, causing them to die. Daunorubicin, doxorubicin, and epirubicin are anthracyclines.
FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

FDA approves new drug combination for hormone positive and HER2-positive advanced breast cancer

FDA grants accelerated approval for GlaxoSmithKline's TYKERB

FDA grants accelerated approval for GlaxoSmithKline's TYKERB

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

Researchers identify new gene signature that predicts cancer recurrence in certain breast tumors

Enzon Pharmaceuticals treats first patient in Phase 2 studies of PEG-SN38

Enzon Pharmaceuticals treats first patient in Phase 2 studies of PEG-SN38

Cell Therapeutics supports Code on Interactions with Healthcare Professionals

Cell Therapeutics supports Code on Interactions with Healthcare Professionals

EMEA grants orphan drug designation for pixantrone in Europe

EMEA grants orphan drug designation for pixantrone in Europe

ODAC to review Cell Therapeutics' NDA for pixantrone

ODAC to review Cell Therapeutics' NDA for pixantrone

Results from five new studies on Genomic Health's Oncotype DX breast cancer test announced

Results from five new studies on Genomic Health's Oncotype DX breast cancer test announced

INS cites FDA-approved Totect antidote for anthracycline extravasations

INS cites FDA-approved Totect antidote for anthracycline extravasations

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Genentech announces Phase III study of Avastin in women treated with chemotherapy for advanced breast cancer

Combination therapy improves overall survival in women with advanced breast cancer

Combination therapy improves overall survival in women with advanced breast cancer

Genentech announces positive results from Phase II study of T-DM1

Genentech announces positive results from Phase II study of T-DM1

ImmunoGen announces the presentation of positive trastuzumab-DM1 clinical data

ImmunoGen announces the presentation of positive trastuzumab-DM1 clinical data

Chemotherapy improves overall survival in postmenopausal breast cancer patients

Chemotherapy improves overall survival in postmenopausal breast cancer patients

Multiple clinical study results of ABRAXANE to be presented by Abraxis BioScience

Multiple clinical study results of ABRAXANE to be presented by Abraxis BioScience

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Pixantrone demonstrates substantial reduction in cardiac cell toxicity compared to anthracyclines

Phase III CLL8 trial shows Rituxan plus FC chemotherapy improves patients with CLL

Phase III CLL8 trial shows Rituxan plus FC chemotherapy improves patients with CLL

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

Results from CytRx's Phase 2 STAR-1 registration clinical trial for tamibarotene announced

Updated results from phase III EXTEND clinical trial of pixantrone released

Updated results from phase III EXTEND clinical trial of pixantrone released

New treatment options for leukemia and myeloproliferative disorders introduced

New treatment options for leukemia and myeloproliferative disorders introduced